RecruitingSpinal Cord Injuries
Feasibility of Early Gabapentin as an Intervention for Neurorecovery
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The objective of the proposed study is to conduct the first ever prospective, dose-exploration trial to test the feasibility of early administration of gabapentin as an intervention for neurorecovery. This research project falls under the Intervention Development stage of research as the primary goal is to assess the feasibility of conducting a well-designed intervention efficacy study in the future.
Sponsor: MetroHealth Medical Center
You may qualify if…
- ✓ 1. Traumatic SCI;
- ✓ 2. All levels of SCI;
- ✓ 3. All severities of SCI, AIS A-D;
- ✓ 4. Age 18 years and older.
- ✓ 5. Agree to participate and start study drug within 120 hours' post-injury.
- ✓ 6. Adequate cognition and communication to provide informed consent
You may not qualify if…
- ✕ 1. Presence of moderate/severe traumatic brain injury (TBI) as defined by Glasgow Coma Score (GCS) \< 13 at 120 hours' post-injury.
- ✕ 2. Documented use of gabapentinoids at the time of injury.
Where it's recruiting
Ohio
Cleveland
Source: ClinicalTrials.gov · NCT05302999 · last updated 2025-12-02